http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32976051

Outgoing Links

Predicate Object
contentType Journal Article
issn 1479-5876
issueIdentifier 1
pageRange 200-
publicationName Journal of Translational Medicine
startingPage 200
bibliographicCitation Xue Y, Xiao R, Long D, Zou X, Wang X, Zhang G, Yuan Y, Wu G, Yang J, Wu Y, Xu H, Liu F, Liu M. Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma. Journal of Translational Medicine. 2012 Sep 24;10(1):200. doi: 10.1186/1479-5876-10-200.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1fb12bb1d30fcf60177538c202888e91
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83b97b1e8b13c66466f952c463821ec9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6168decf4e100d9fd48be8736a0eb7f1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e132710d3136fe4b297a53b9702e750
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86db48b851b41dfcb7e85d2f045e0a10
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0ec157a0e46ca1e0a97f0422073300b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ae9db9fcaa1e5d23ce2df07febd64fa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5debc7c99745c05235cc39523297641a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7744399e5c1a05c40ee634f3c0feebf1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5bf264cc4415f61d1dff2403a3e0ead1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32c1b5986a64c708c7f29a988ccf4d12
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01cb9181886bfed383e8000fbd1f0b52
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_976788afbb2462f5836b7aede6da555b
date 2012-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC3492118
https://pubmed.ncbi.nlm.nih.gov/23006512
https://doi.org/10.1186/1479-5876-10-200
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/31680
https://portal.issn.org/resource/ISSN/1479-5876
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma
discusses http://id.nlm.nih.gov/mesh/M0019167
http://id.nlm.nih.gov/mesh/M000616723
http://id.nlm.nih.gov/mesh/M0279832
http://id.nlm.nih.gov/mesh/M0027090
http://id.nlm.nih.gov/mesh/M0166232
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f6e823973728aec8c3075d39388b14dd
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.24.24
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_582d5f2f504253c89e3a8210d6134600
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6600c5cd2493e3a8f413e3b3388d00c7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_42e5c8717e13ca9e92807498eccbf953
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8382
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_63a9c446da97985db610d03a02fcdbd9
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bf99a94c673fe4e93461af6be7e99f9e
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_24fcc8ae2c4a3fc4fe2b5ecda59a20f4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a95421c679462609c9ef4e68005e1dcc
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f7f9050e59c89962f38190b76545ac23
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b30b0b608593935259123d48ab1a931d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7826c784e8fc911de47e7fb31a96992f
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_75be19437755fc2af3f5756d6bb1d737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10509
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b8b61580f3b0744d9098586a01c34cc3

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2305

Total number of triples: 58.